We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBI
876
Trueblue
TBI
$317M
| $4.68M | 0.01% |
+194,663
| New | +$4.44M |
|
877
CNA Financial
CNA
$13.9B
| $4.68M | 0.01% |
+104,394
| New | +$4.71M |
|
|
OMP
878
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
| $4.63M | 0.01% |
279,042
+99,439
| +55% | +$1.66M |
|
879
SM Energy
SM
$7.51B
| $4.63M | 0.01% |
411,671
-776,056
| -65% | -$6.99M |
|
|
VLRS
880
Controladora Vuela Compania de Aviacion
VLRS
$928M
| $4.58M | 0.01% |
+439,886
| New | +$4.69M |
|
|
SGEN
881
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.57M | 0.01% |
+39,986
| New | +$4.24M |
|
882
Pfizer
PFE
$154B
| $4.56M | 0.01% |
122,791
+52,595
| +75% | +$1.87M |
|
883
Texas Capital Bancshares
TCBI
$4.31B
| $4.54M | 0.01% |
+80,000
| New | +$4.56M |
|
884
Hess Midstream
HESM
$5.21B
| $4.52M | 0.01% |
199,442
-39,329
| -16% | -$823K |
|
885
Maximus
MMS
$2.95B
| $4.48M | 0.01% |
60,235
-63,725
| -51% | -$4.79M |
|
886
Lumen
LUMN
$6.92B
| $4.47M | 0.01% |
+338,600
| New | +$4.54M |
|
887
Powell Industries
POWL
$7.55B
| $4.45M | 0.01% |
272,601
+233,601
| +599% | +$3.28M |
|
888
US Bancorp
USB
$99.8B
| $4.44M | 0.01% |
74,926
-2,687,462
| -97% | -$155M |
|
889
Conduent
CNDT
$253M
| $4.42M | 0.01% |
+713,631
| New | +$4.46M |
|
890
Napco Security Technologies
NSSC
$1.45B
| $4.42M | 0.01% |
301,044
-3,192
| -1% | -$46.3K |
|
891
Erie Indemnity
ERIE
$13.1B
| $4.42M | 0.01% |
26,600
+9,700
| +57% | +$1.71M |
|
892
Outfront Media
OUT
$5.35B
| $4.41M | 0.01% |
167,142
+86,755
| +108% | +$2.23M |
|
|
ARCE
893
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $4.41M | 0.01% |
99,740
+87,657
| +725% | +$3.9M |
|
|
DRNA
894
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.4M | 0.01% |
+199,801
| New | +$4.02M |
|
895
Knowles
KN
$3.31B
| $4.39M | 0.01% |
+207,397
| New | +$4.45M |
|
|
NEX
896
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $4.38M | 0.01% |
654,368
+346,865
| +113% | +$1.87M |
|
897
Par Pacific Holdings
PARR
$3.62B
| $4.37M | 0.01% |
187,915
+81,645
| +77% | +$1.95M |
|
898
Red Robin
RRGB
$148M
| $4.37M | 0.01% |
+132,268
| New | +$3.9M |
|
899
Calix
CALX
$2.47B
| $4.36M | 0.01% |
544,445
-2
| -0% | -$15 |
|
|
HTBK
900
DELISTED
Heritage Commerce
HTBK
| $4.35M | 0.01% |
339,372
+28,539
| +9% | +$347K |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.